Table 2. Age-Specific Cancer Incidence Ratesa per 100,000 Population, Alaska Native and US White Men and Women, 2000–2011.
| Cancer Site/Age Group, y | Men |
Women |
||||||
|---|---|---|---|---|---|---|---|---|
| No. | Alaska Native Rate | US White Rate | Rate Ratio (P Value) | No. | Alaska Native Rate | US White Rate | Rate Ratio (P value) | |
| All sites | ||||||||
| 30–39 | 84 | 98.4 | 81.6 | 1.20 (.11) | 135 | 159.2 | 147.2 | 1.08 (.39) |
| 40–49 | 195 | 214.6 | 211.8 | 1.01 (.88) | 358 | 392.4 | 355.7 | 1.10 (.07) |
| 50–59 | 424 | 646.4 | 712.6 | 0.90 (.04) | 550 | 818.4 | 684.0 | 1.19 (<.001) |
| 60–69 | 535 | 1,556.8 | 1,841.0 | 0.84 (<.001) | 552 | 1,519.3 | 1,234.4 | 1.23 (<.001) |
| 70–79 | 485 | 2,827.2 | 2,938.4 | 0.96 (.41) | 470 | 2,272.4 | 1,788.4 | 1.27 (<.001) |
| ≥80 | 188 | 3,217.2 | 3,212.3 | 1.00 (>.99) | 209 | 2,210.8 | 1,978.5 | 1.11 (.12) |
| Stomach | ||||||||
| 30–39 | 5 | 5.8 | 1.4 | 4.08 (.02) | 11 | 13.2 | 1.2 | 11.13 (<.001) |
| 40–49 | 20 | 21.8 | 4.1 | 5.30 (<.001) | 11 | 11.9 | 2.7 | 4.44 (<.001) |
| 50–59 | 23 | 35.1 | 11.2 | 3.14 (<.001) | 11 | 16.4 | 5.3 | 3.07 (<.001) |
| 60–69 | 22 | 67.0 | 28.1 | 2.38 (<.001) | 20 | 55.0 | 11.2 | 4.89 (<.001) |
| 70–79 | 25 | 151.0 | 51.3 | 2.94 (<.001) | 18 | 87.9 | 22.6 | 3.89 (<.001) |
| ≥80 | 12 | 222.4 | 72.2 | 3.08 (<.001) | 4 | 42.0 | 36.4 | 1.15 (.91) |
| Colon and rectum | ||||||||
| 30–39 | 13 | 15.2 | 6.7 | 2.25 (.01) | 8 | 9.3 | 6.0 | 1.55 (.30) |
| 40–49 | 35 | 38.5 | 22.9 | 1.67 (.01) | 52 | 57.0 | 19.7 | 2.89 (<.001) |
| 50–59 | 78 | 118.9 | 71.6 | 1.66 (<.001) | 79 | 117.5 | 51.5 | 2.28 (<.001) |
| 60–69 | 106 | 303.5 | 160.4 | 1.89 (<.001) | 87 | 241.0 | 106.7 | 2.25 (<.001) |
| 70–79 | 93 | 540.4 | 293.9 | 1.83 (<.001) | 109 | 528.3 | 209.2 | 2.52 (<.001) |
| ≥80 | 35 | 611.1 | 402.4 | 1.51 (.03) | 47 | 497.7 | 323.2 | 1.54 (.01) |
| Lung | ||||||||
| 30–39 | 3 | 3.5 | 2.2 | 1.60 (.58) | 1 | 1.1 | 2.5 | 0.43 (.70) |
| 40–49 | 20 | 21.7 | 16.8 | 1.29 (.31) | 20 | 21.5 | 17.0 | 1.26 (.35) |
| 50–59 | 83 | 126.4 | 78.1 | 1.61 (<.001) | 53 | 78.9 | 63.6 | 1.23 (.14) |
| 60–69 | 114 | 328.8 | 262.2 | 1.25 (.02) | 102 | 283.4 | 197.3 | 1.43 (<.001) |
| 70–79 | 143 | 827.3 | 505.8 | 1.63 (<.001) | 119 | 577.1 | 344.5 | 1.67 (<.001) |
| ≥80 | 46 | 785.8 | 524.9 | 1.49 (.01) | 42 | 446.7 | 300.0 | 1.48 (.02) |
| Breast | ||||||||
| 30–39 | — | — | — | — | 48 | 57.2 | 43.8 | 1.30 (.09) |
| 40–49 | — | — | — | — | 166 | 182.5 | 154.4 | 1.18 (.04) |
| 50–59 | — | — | — | — | 203 | 302.1 | 260.7 | 1.15 (.04) |
| 60–69 | — | — | — | — | 162 | 444.7 | 398.1 | 1.11 (.18) |
| 70–79 | — | — | — | — | 87 | 420.0 | 460.4 | 0.91 (.43) |
| ≥80 | — | — | — | — | 23 | 244.4 | 412.3 | 0.59 (.01) |
| Prostate | ||||||||
| 30–39 | 2 | 2.4 | 0.5 | 5.03 (.12) | — | — | — | — |
| 40–49 | 11 | 11.8 | 22.4 | 0.52 (.03) | — | — | — | — |
| 50–59 | 65 | 98.9 | 210.8 | 0.46 (<.001) | — | — | — | — |
| 60–69 | 101 | 292.5 | 681.2 | 0.42 (<.001) | — | — | — | — |
| 70–79 | 63 | 366.5 | 899.7 | 0.40 (<.001) | — | — | — | — |
| ≥80 | 28 | 468.9 | 642.7 | 0.72 (.11) | — | — | — | — |
| Kidney | ||||||||
| 30–39 | 6 | 7.3 | 3.8 | 1.92 (.19) | 4 | 4.7 | 2.6 | 1.78 (.38) |
| 40–49 | 13 | 14.3 | 13.6 | 1.05 (.93) | 5 | 5.5 | 7.4 | 0.74 (.68) |
| 50–59 | 29 | 44.2 | 33.8 | 1.30 (.19) | 24 | 35.7 | 16.6 | 2.14 (<.001) |
| 60–69 | 30 | 87.5 | 68.4 | 1.27 (.22) | 15 | 40.3 | 32.5 | 1.24 (.47) |
| 70–79 | 29 | 170.3 | 93.8 | 1.81 (<.001) | 14 | 65.8 | 46.2 | 1.42 (.25) |
| ≥80 | 7 | 108.9 | 91.2 | 1.19 (.75) | 9 | 96.3 | 44.3 | 2.17 (.05) |
a
Source of data: Surveillance Epidemiology and End Results (SEER) program SEER*Stat database (17).